SF3B1 and glioma: Moreover, bioinformatic analyses revealed a potential diagnostic capacity of SF3B1 levels to discriminate between GBM/gliomas vs. control tissues from humans and mice, suggesting that GBM/glioma curse with a global dysregulation of SF3B1 in different species.